Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis - Lallas, Konstantinos; Chatziioannou, Eftychia; Durak, Derya; Frey, Georg; Serna-Higuita, Lina Maria; Rasch, Marie-Lena; Kyrgidis, Athanassios; Timotheadou, Eleni; Apalla, Zoe; Leiter, Ulrike; Flatz, Lukas; Lallas, Aimilios; et al. (Frontiers in Immunology, 2025)